EMILIN1 and gastric adenocarcinoma: The increase in the poor prognostic impact of CAFs in stomach adenocarcinoma with the addition of EMILIN1 as a covariate to the Cox model was surprising since EMILIN-1 is known as a tumor suppressor that exerts anti-proliferative action via integrin α4β1 in cell and in vivo models [50, 53].